| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2001 ( Subtotal = $314,561 ) |
| 2001 | 2001 | NEORX CORPORATION | 410 WEST HARRISON STREET | SEATTLE | WA | 98119 | KING | USA | Cancer Treatment Research | 000 | 5 | 4/16/2001 | NON-COMPETING CONTINUATION | $314,561 |
|
 | Issue Date FY: 2000 ( Subtotal = $12,571 ) |
| 2000 | 2000 | NEORX CORPORATION | 410 WEST HARRISON STREET | SEATTLE | WA | 98119 | KING | USA | Cancer Treatment Research | 000 | 4 | 5/19/2000 | NON-COMPETING CONTINUATION | $12,571 |
|
 | Issue Date FY: 1999 ( Subtotal = $46,715 ) |
| 1999 | 1999 | NEORX CORPORATION | 410 WEST HARRISON STREET | SEATTLE | WA | 98119 | KING | USA | Cancer Treatment Research | 001 | 2 | 5/28/1999 | SUPPLEMENT FOR EXPANSION | $634 |
| 1999 | 1999 | NEORX CORPORATION | 410 WEST HARRISON STREET | SEATTLE | WA | 98119 | KING | USA | Cancer Treatment Research | 000 | 3 | 5/31/1999 | NON-COMPETING CONTINUATION | $46,081 |
|
 | Issue Date FY: 1998 ( Subtotal = $378,164 ) |
| 1998 | 1998 | NEORX CORPORATION | 410 WEST HARRISON STREET | SEATTLE | WA | 98119 | KING | USA | Cancer Treatment Research | 000 | 2 | 4/17/1998 | COMPETING CONTINUATION | $378,164 |
|
|